Cure8 research brief
Patients and families should know that colonoscopy appearance and biopsy (microscopic) inflammation do not always match; microscopic inflammation may persist despite clinical improvement, which can affect monitoring and treatment decisions.
Pediatric patients with IBD, parents and caregivers, pediatric gastroenterologists, and researchers studying pediatric IBD monitoring and outcomes.
This retrospective pediatric study compared recorded colonoscopic findings with histopathology reports in children with ulcerative colitis, Crohn disease, or IBD-unclassified.
Colonoscopic feature counts and histopathological feature counts were moderately correlated overall (Spearman rho ≈0.49), with a stronger correlation in Crohn disease than ulcerative colitis.
Among 47 children with paired biopsies before and after treatment, the proportion with reported microscopic inflammation fell from about 60% to about 32% overall; subgroup changes did not reach conventional statistical significance when UC and CD were examined separately.
The study used retrospective chart data from a single tertiary pediatric center (2003–2016). Histology assessments were taken from original pathology reports (active vs inactive) rather than validated histologic scoring systems, and endoscopic findings were summarized descriptively without validated endoscopic scores.
Treatment details and timing were incompletely captured, so the observed changes in microscopic activity cannot be firmly attributed to specific therapies.
Bottom line: endoscopic appearance and biopsy-reported microscopic inflammation are related but not interchangeable; clinicians and families should be aware microscopic inflammation can persist even when symptoms improve.
This is a retrospective single-center study using non-validated exploratory counts and categorical pathology reports rather than formal histologic scoring systems. Treatment regimens and timing were not fully captured, limiting causal interpretation. The article is an abstract-level report of the study.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Distinguishing UC from Crohn’s colitis can be challenging but affects long-term management and surveillance. A histologic feature—homogeneity versus heterogeneity of epithelial lesions across biopsies—might help improve...
The review highlights that colorectal IBD is under-recognized and often mistaken for infectious colitis in sub‑Saharan Africa due to limited diagnostic and specialist resources, which can delay appropriate care.
Distinguishing IBD from gastrointestinal tuberculosis is challenging in regions where GITB is common; histologic markers like basal plasmacytosis and eosinophilia on mucosal biopsy could help guide diagnosis when...
